Press Release: NeuroDeRisk – Cracking the code of neurotoxicity

NeuroDeRisk will foster the development of innovative and safer pharmaceuticals: A new consortium of 18 international partners from academia, industry, and small and medium enterprises, aims to tackle the unmet challenge of poor prediction of neurotoxic effects in pre- clinical drug candidate assessment.